Cue Biopharma Announces 1-For-30 Reverse Stock Split Effective After Market Close On April 23

Benzinga Newsdesk www.benzinga.com Neutral 85.1%

Neg 0% Neu 85.1% Pos 0%

Comments

No comments yet. Be the first!